EPISODE · Jun 22, 2026 · 8 MIN
When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma
from Oncology Learning Network · host HMP Global
Samantha Shenoy, NP, and Caitlin Costello, MD, discuss how risk stratification, early relapse patterns, and changes in disease trajectory can help oncology care teams recognize when a patient with multiple myeloma may warrant consideration for cellular therapy, including CAR T-cell therapy. The episode highlights the role of nurses and advanced practice providers in identifying clinical shifts and supporting timely multidisciplinary discussion.
Embed this episode
Ready to play
When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.